FindTrial
Sign In

Prevalence and clinical significance of portal vein thrombosis in liver cirrhosis: A retrospective cohort study

Prevalence and clinical significance of portal vein thrombosis in liver cirrhosis: A retrospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-14005006
Enrollment
Unknown
Registered
2014-05-30
Start date
2014-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis

Interventions

Liver cirrhosis:Portal vein thrombosis

Sponsors

Department of Gastroenterology, General Hospital of Shenyang Military Region
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with liver cirrhosis admitted between 2011 and 2013; 2. Concomitant diseases were not restricted; 3. Age and sex were not restricted.

Exclusion criteria

Exclusion criteria: 1. No diagnosis of liver cirrhosis; 2. Malignancy, especially hepatocellular carcinoma; 3. No data regarding portal vein patency or obstruction.

Design outcomes

Primary

MeasureTime frame
Prevalence of portal vein thrombosis in liver cirr;Survival between cirrhotic patients with and witho;—

Secondary

MeasureTime frame
Survival between cirrhotic patients with and without portal vein thrombosis;—

Countries

China

Contacts

Public ContactXiaozhong Guo
guoxiaozhong1962@163.com+86 024 28897603

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026